Table 2.
Multinomial logistic regression: Relative risk of higher clinical stage breast cancer.
| Factor | Stage 1 |
P value | Stage 2 |
P value | Stage 3 or 4 |
P value |
|---|---|---|---|---|---|---|
| RRR (95% CI) | RRR (95% CI) | RRR (95% CI) | ||||
| Post-COVID-19 | 1 (0.68-1.46) | 0.988 | 0.86 (0.51-1.45) | 0.567 | 0.89 (0.51-1.45) | 0.702 |
| Demographic | ||||||
| Age (per year increase) | 1.04 (1.02-1.06) | 0.001 | 1 (0.97-1.02) | 0.77 | 1 (0.97-1.02) | 0.974 |
| Race | ||||||
| White | Ref. | -- | Ref. | -- | Ref. | -- |
| Black | 0.52 (0.26-1.02) | 0.056 | 0.73 (0.29-1.85) | 0.502 | 0.95 (0.29-1.85) | 0.913 |
| Asian | 0.69 (0.26-1.82) | 0.456 | 0.8 (0.21-3.03) | 0.743 | 0.8 (0.21-3.03) | 0.767 |
| Other/Unknown | 1.99 (0.92-4.29) | 0.08 | 2.5 (0.97-6.44) | 0.059 | 1.1 (0.97-6.44) | 0.862 |
| Ethnicity | ||||||
| Not Hispanic | Ref. | -- | Ref. | -- | Ref. | -- |
| Hispanic | 0.55 (0.33-0.92) | 0.022 | 0.55 (0.27-1.12) | 0.099 | 0.69 (0.27-1.12) | 0.344 |
| Unknown | 0.63 (0.31-1.25) | 0.184 | 0.5 (0.18-1.44) | 0.2 | 1.26 (0.18-1.44) | 0.655 |
| Insurance | ||||||
| Private | Ref. | -- | Ref. | -- | Ref. | -- |
| Medicare | 0.68 (0.38-1.21) | 0.19 | 1.07 (0.47-2.4) | 0.875 | 1.88 (0.47-2.4) | 0.167 |
| Medicaid | 0.7 (0.33-1.49) | 0.357 | 2.12 (0.86-5.22) | 0.103 | 5.18 (0.86-5.22) | 0.001 |
| Uninsured | 2.3 (0.86-6.16) | 0.098 | 8.07 (2.68-24.25) | <0.001 | 14.52 (2.68-24.25) | <0.001 |
| Unknown/Insurance not otherwise specified | 1.2 (0.54-2.66) | 0.653 | 0.83 (0.24-2.88) | 0.775 | 0.78 (0.24-2.88) | 0.765 |
| Treatment characteristic | ||||||
| Time to first intervention (per day increase) | 1 (0.99-1) | 0.156 | 0.98 (0.98-0.99) | 0.001 | 0.99 (0.98-0.99) | 0.018 |
Bold: statistically significant, P < 0.05.
CI = confidence interval; RRR = relative risk ratio.